Please login to the form below

Not currently logged in
Email:
Password:

S-A launches £50,000 patient group bursary

Sanofi-aventis has strengthened its support for patient groups in the UK with the launch of a new patient group bursary

Sanofi-aventis (S-A) has strengthened its support for patient groups in the UK with the launch of a new £50,000 patient group bursary.

With the NHS in England set to undergo major structural and cultural change through the implementation of the government's far-reaching healthcare plans, S-A said it believes that patient groups will have a more important role in championing the needs of individual patients and improving the quality of their care.

The patient group bursary scheme invites applications from all patient groups, including local groups, social enterprises or professional associations proposing projects in three key categories:

• Developing capacity to deliver health services to the NHS
• Improving and promoting patient empowerment and information
• Reducing health inequalities.

As part of the 2011 scheme, two groups will be awarded grants of £25,000 each to support new programmes in the above areas running throughout the year.

Announcing the new scheme, S-A UK general manager, Steve Oldfield, said: "This is an exciting development that reaffirms our commitment to working in partnership with patient groups to meet the needs of professionals and patients in the NHS alike."

A panel of judges, chaired by Steve Oldfield and including the Liberal Democrat Peer and former chief executive of the King's Fund, Baroness Julia Neuberger, and Baroness Jill Pitkeathley, chair of the Council of Healthcare Regulatory Excellence (CHRE), will meet to assess applications and decide the winning programmes in May.

Applications for the scheme will close on April 20, 2011.

S-A has more informaiton on how to apply for the bursary.

The winning programmes will be announced in May.

29th March 2011

From: Healthcare

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics